COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
80.48 EUR
-0.42 (-0.52%)
Overall CBHD gets a fundamental rating of 5 out of 10. We evaluated CBHD against 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are concerns on its financial health. CBHD is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
CBHD had positive earnings in 4 of the past 5 years.
CBHD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 8.51%, CBHD belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
CBHD has a better Return On Equity (24.78%) than 90.00% of its industry peers.
CBHD has a Return On Invested Capital of 15.96%. This is amongst the best in the industry. CBHD outperforms 96.67% of its industry peers.
CBHD had an Average Return On Invested Capital over the past 3 years of 16.81%. This is significantly above the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROIC | 15.96% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
CBHD has a Profit Margin of 14.62%. This is amongst the best in the industry. CBHD outperforms 83.33% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
CBHD has a better Operating Margin (26.99%) than 96.67% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
With a decent Gross Margin value of 67.55%, CBHD is doing good in the industry, outperforming 76.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
There is no outstanding debt for CBHD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CBHD has an Altman-Z score of 4.02. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD has a Altman-Z score of 4.02. This is in the better half of the industry: CBHD outperforms 68.33% of its industry peers.
CBHD has a debt to FCF ratio of 4.89. This is a neutral value as CBHD would need 4.89 years to pay back of all of its debts.
CBHD's Debt to FCF ratio of 4.89 is in line compared to the rest of the industry. CBHD outperforms 60.00% of its industry peers.
CBHD has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
CBHD's Debt to Equity ratio of 1.05 is on the low side compared to the rest of the industry. CBHD is outperformed by 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 4.02 |
ROIC/WACC2.63
WACC6.07%
2.3 Liquidity
A Current Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.00, CBHD is doing worse than 76.67% of the companies in the same industry.
CBHD has a Quick Ratio of 1.00. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CBHD (0.64) is worse than 81.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -39.34% in the last year.
The Earnings Per Share has been decreasing by -7.08% on average over the past years.
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.74%
3.2 Future
CBHD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.56% yearly.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.53% yearly.
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CBHD is valuated quite expensively with a Price/Earnings ratio of 44.22.
CBHD's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (25.89), we can say CBHD is valued expensively.
The Price/Forward Earnings ratio is 23.23, which indicates a rather expensive current valuation of CBHD.
The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (34.59), we can say CBHD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.22 | ||
| Fwd PE | 23.23 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is in line with the industry average.
CBHD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 68.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.53 | ||
| EV/EBITDA | 16.96 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBHD may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 35.02% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y45.02%
EPS Next 3Y35.02%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.75%, CBHD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.37, CBHD pays a better dividend. On top of this CBHD pays more dividend than 96.67% of the companies listed in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.75% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
121.67% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP121.67%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
FRA:CBHD (11/14/2025, 7:00:00 PM)
80.48
-0.42 (-0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.92B
Revenue(TTM)N/A
Net Income(TTM)4.08B
Analysts68.46
Price Target92.76 (15.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.75% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP121.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.87%
Min EPS beat(2)-22.36%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-13.35%
Min EPS beat(4)-22.36%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-10.21%
EPS beat(12)0
Avg EPS beat(12)-8.91%
EPS beat(16)1
Avg EPS beat(16)-7.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.36%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)-1.86%
PT rev (3m)-7.49%
EPS NQ rev (1m)2.86%
EPS NQ rev (3m)0.79%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-15.46%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.22 | ||
| Fwd PE | 23.23 | ||
| P/S | 4.53 | ||
| P/FCF | 25.53 | ||
| P/OCF | 19.65 | ||
| P/B | 7.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.96 |
EPS(TTM)1.82
EY2.26%
EPS(NY)3.46
Fwd EY4.31%
FCF(TTM)3.15
FCFY3.92%
OCF(TTM)4.1
OCFY5.09%
SpS17.75
BVpS10.48
TBVpS-8.58
PEG (NY)0.49
PEG (5Y)N/A
Graham Number20.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROCE | 20.15% | ||
| ROIC | 15.96% | ||
| ROICexc | 16.27% | ||
| ROICexgc | 89.1% | ||
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% | ||
| FCFM | 17.76% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexgc growth 3Y7.74%
ROICexgc growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Debt/EBITDA | 1.95 | ||
| Cap/Depr | 109.63% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 72.46% | ||
| Profit Quality | 121.42% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 4.02 |
F-Score6
WACC6.07%
ROIC/WACC2.63
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.74%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
EBIT growth 1Y4.5%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year22.79%
EBIT Next 3Y12.78%
EBIT Next 5Y11.74%
FCF growth 1Y53.38%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y43.32%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 3 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 89.92% in the next year.